259 results on '"Wilder, Richard B."'
Search Results
2. A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer
3. Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: A population-based analysis
4. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy ± intensity modulated radiation therapy
5. High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy
6. Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer
7. Radiotherapy Treatment Planning for Testicular Seminoma
8. ACR Appropriateness Criteria® on Hodgkin's Lymphoma-Unfavorable Clinical Stage I and II
9. Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy
10. Cross-Linked Hyaluronan Gel Reduces the Acute Rectal Toxicity of Radiotherapy for Prostate Cancer
11. Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone
12. Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patients
13. Results With Accelerated Partial Breast Irradiation in Terms of Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor 2 Status
14. A Prospective Study of Intrafraction Prostate Motion in the Prone vs. Supine Position
15. A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation
16. ACR Appropriateness Criteria® Pediatric Hodgkin Lymphoma
17. Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer
18. Two-Staged Radiosurgical Treatment of Large Arteriovenous Malformations
19. Preliminary Results in 173 Breast Cancer Patients Treated with Post-Lumpectomy MammoSite Single-Lumen Brachytherapy or Multi-Catheter Brachytherapy
20. LONG-TERM SALVAGE RADIOTHERAPY OUTCOME AFTER RADICAL PROSTATECTOMY AND RELAPSE PREDICTORS
21. Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy
22. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated franctionation radiation therapy after chemotherapy
23. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease
24. International prognostic index-based outcomes for diffuse large B-cell lymphomas
25. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma
26. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease
27. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone
28. Results with chemotherapy comparised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma
29. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II
30. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation
31. Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapy
32. Central lymphatic irradiation for stage I–III follicular lymphoma: report from a single-institutional prospective study
33. Stage III follicular lymphoma: long-term follow-up and patterns of failure
34. Hematologic recovery after central lymphatic irradiation for patients with Stage I-III follicular lymphoma
35. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy
36. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma
37. Localized non-Hodgkin lymphoma involving the thyroid gland
38. Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas
39. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy
40. Long-term results with radiotherapy for stage I–II follicular lymphomas
41. Merkel cell carcinoma: improved locoregional control with postoperative radiation therapy
42. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III–IV, intermediate grade and large-cell immunoblastic lymphomas
43. Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy
44. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
45. Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans
46. Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses
47. Recent advances in radiotherapy for head and neck cancers
48. Testicular Cancer, Version 2.2015
49. Dosimetric Coverage of the Prostate, Normal Tissue Sparing, and Acute Toxicity with High-Dose-Rate Brachytherapy for Large Prostate Volumes
50. Kidney Cancer, Version 3.2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.